title: The Evergreening of Biopharmaceuticals: Time to Defoliate.
authors.affiliation: SUNY Upstate Medical University, Syracuse, NY, USA.
authors.forename: David F
authors.initials: DF
authors.lastname: Lehmann
authors.affiliation: SUNY Upstate Medical University, Syracuse, NY, USA.
authors.forename: Sarabeth
authors.initials: S
authors.lastname: Wojnowicz
mesh_terms: D001249:Asthma / Q000188:drug therapy; D001702:Biopharmaceutics / Q000379:methods*; D015283:Citalopram / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy; D004345:Drug Industry / Q000379:methods*; D064098:Esomeprazole / Q000627:therapeutic use; D006801:Humans; D064412:Levalbuterol / Q000627:therapeutic use; D040541:Marketing / Q000379:methods; D013237:Stereoisomerism
chemical_list: D015283:Citalopram; D064412:Levalbuterol; D064098:Esomeprazole
keywords: biopharmaceuticals; cost; outcomes; racemic mixture; single enantiomer; value